Association of chondroadherin with leiomyosarcoma

The leiomyosarcoma (LMS) subtype of uterine sarcoma accounts for 1–2 % of uterine neoplasia cases. The present study aimed to demonstrate that the gene and protein chondroadherin (CHAD) levels may serve as novel biomarkers for predicting prognosis and devising novel treatment models for LMS. A total...

Descripción completa

Detalles Bibliográficos
Autores principales: Gokce, Sefik, Herkiloglu, Dilsad, İsik Kaygusuz, Ecmel, Cevik, Ozge, Ahmad, Sarfraz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Special Section on Global Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969241/
https://www.ncbi.nlm.nih.gov/pubmed/36860591
http://dx.doi.org/10.1016/j.gore.2023.101144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969241/
https://www.ncbi.nlm.nih.gov/pubmed/36860591
http://dx.doi.org/10.1016/j.gore.2023.101144

Ejemplares similares